CLOS
AMGN icon

Compagnie Lombard Odier SCmA’s Amgen AMGN Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-6,000
Closed -$60K – 706
2017
Q1 		$60K Hold
6,000
– – ﹤0.01% 521
2016
Q4 		$31K Hold
6,000
– – ﹤0.01% 662
2016
Q3 		$91K Buy
6,000
+500
+9% +$84.6K ﹤0.01% 589
2016
Q2 		$20K Hold
5,500
– – ﹤0.01% 781
2016
Q1 		$31K Sell
5,500
-7,200
-57% -$1.07M ﹤0.01% 777
2015
Q4 		$275K Buy
+12,700
New +$2M 0.01% 426

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Compagnie Lombard Odier SCmA's AMGN Position: Q2 2025 in Review

Compagnie Lombard Odier SCmA sold out of Amgen (AMGN) in Q2 2025, closing a stake of 210,896 shares — an estimated $65.7M sold.

Compagnie Lombard Odier SCmA first reported a position in AMGN in Q4 2013 and held it in 41 quarters. The position peaked at $106M in Q3 2014. 2,852 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Compagnie Lombard Odier SCmA reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 210,896 Amgen shares in Q2 2025, an estimated $65.7M.
  • Compagnie Lombard Odier SCmA first reported a position in Amgen in Q4 2013 and held it in 41 quarters.
  • Compagnie Lombard Odier SCmA's Amgen position peaked at $106M in Q3 2014.
  • 2,852 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2025, filed 15 Jul 2025.